FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to a heterocyclic compound of formula (IIB) or a pharmaceutically acceptable salt thereof, where E denotes -CH2-; Q is -CH2- or -CH2O-; Z is hydrogen or methyl; V denotes CR22 or N; R15 denotes a halogen or difluoromethoxy group; R16 is hydrogen or halogen; R21 denotes hydroxy, methoxy, piperazinyl or morpholinyl; R22 denotes hydrogen and R23 denotes hydrogen. Invention also relates to a pharmaceutical composition based on a compound of formula (IIB), use thereof and a method of treating and/or preventing rheumatoid arthritis or Crohn's disease.
EFFECT: obtaining novel heterocyclic compounds having the properties of a TNFα activity modulator.
7 cl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
| IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2683318C1 |
| PURINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684644C1 |
| IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677699C1 |
| CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
| CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2687093C1 |
| PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2684641C1 |
| CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
| TETRAHYDROIMIDAZOPYRIDINE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684635C1 |
| IMIDAZOPYRIMIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2691629C1 |
Authors
Dates
2019-07-25—Published
2014-12-08—Filed